Sort   by:  
 Page size 
UnknownChallenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) study.
Not available
S-EPMC6360765 | biostudies-literature
UnknownDevice-measured physical activity and sedentary time in a national sample of Luxembourg residents: the ORISCAV-LUX 2 study.
Not available
S-EPMC9798598 | biostudies-literature
UnknownMicronutrients and Markers of Oxidative Stress and Inflammation Related to Cardiometabolic Health: Results from the EHES-LUX Study.
Not available
S-EPMC7822009 | biostudies-literature
UnknownAssociations Between Wearable-Specific Indicators of Physical Activity Behaviour and Insulin Sensitivity and Glycated Haemoglobin in the General Population: Results from the ORISCAV-LUX 2 Study.
Not available
S-EPMC9743939 | biostudies-literature
UnknownAfatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial.
Not available
S-EPMC4769992 | biostudies-literature
UnknownAssociation of diet quality indices with serum and metabolic biomarkers in participants of the ORISCAV-LUX-2 study.
Not available
S-EPMC10349755 | biostudies-literature
UnknownThe effect of a dynamic lighting schedule on neurobehavioral performance during a 45-day simulated space mission.
Not available
S-EPMC11187988 | biostudies-literature
UnknownUltrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.
Not available
S-EPMC5627731 | biostudies-literature
UnknownCombating lead and cadmium exposure with an orally administered chitosan-based chelating polymer.
Not available
S-EPMC9905611 | biostudies-literature
UnknownProton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.
Not available
S-EPMC5327359 | biostudies-literature
Sort   by:  
 Page size